Log In
Print
BCIQ
Print
Print this Print this
 

Rx-04

  Manage Alerts
Collapse Summary General Information
Company Melinta Therapeutics Inc.
DescriptionBroad spectrum multi-drug resistant Gram-negative and Gram-positive antibiotic
Molecular Target Ribosomal 50S subunit
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today